"Adrenocortical Adenoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A benign neoplasm of the ADRENAL CORTEX. It is characterized by a well-defined nodular lesion, usually less than 2.5 cm. Most adrenocortical adenomas are nonfunctional. The functional ones are yellow and contain LIPIDS. Depending on the cell type or cortical zone involved, they may produce ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE.
| Descriptor ID |
D018246
|
| MeSH Number(s) |
C04.588.322.078.265.500 C19.053.098.265.500 C19.053.347.500.500 C19.344.078.265.500
|
| Concept/Terms |
Adrenocortical Adenoma- Adrenocortical Adenoma
- Adenomas, Adrenocortical
- Adrenocortical Adenomas
- Adenoma, Adrenocortical
- Adenoma, Adrenal Cortical
- Adenomas, Adrenal Cortical
- Adrenal Cortical Adenoma
- Adrenal Cortical Adenomas
Conn Adenoma- Conn Adenoma
- Adenoma, Conn
- Adenomas, Conn
- Conn Adenomas
- Conn's Disease
- Conns Disease
- Disease, Conn's
- Conn Disease
- Disease, Conn
|
Below are MeSH descriptors whose meaning is more general than "Adrenocortical Adenoma".
Below are MeSH descriptors whose meaning is more specific than "Adrenocortical Adenoma".
This graph shows the total number of publications written about "Adrenocortical Adenoma" by people in this website by year, and whether "Adrenocortical Adenoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adrenocortical Adenoma" by people in Profiles.
-
High LDL Particle and APOB Concentrations in Patients With Adrenal Cortical Adenomas. J Clin Endocrinol Metab. 2024 Dec 18; 110(1):195-207.
-
Kidney Function in Patients With Adrenal Adenomas: A Single-Center Retrospective Cohort Study. J Clin Endocrinol Metab. 2024 Aug 13; 109(9):e1750-e1758.
-
Risk of dementia and psychiatric or sleep disorders after diagnosis of adrenal adenomas: a population-based cohort study. Eur J Endocrinol. 2023 Oct 17; 189(4):429-437.
-
Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism. Nat Genet. 2023 10; 55(10):1623-1631.
-
High prevalence of frailty in patients with adrenal adenomas and adrenocortical hormone excess: a cross-sectional multi-centre study with prospective enrolment. Eur J Endocrinol. 2023 Sep 01; 189(3):318-326.
-
Multicenter Validation of a T2-Weighted MRI Calculator to Differentiate Adrenal Adenoma From Adrenal Metastases. AJR Am J Roentgenol. 2024 01; 222(1):e2329727.
-
Development of Human Adrenocortical Adenoma (HAA1) Cell Line from Zona Reticularis. Int J Mol Sci. 2022 Dec 29; 24(1).
-
Cardiometabolic Outcomes and Mortality in Patients with Adrenal Adenomas in a Population-based Setting. J Clin Endocrinol Metab. 2021 10 21; 106(11):3320-3330.
-
Imaging characteristics of pathologically proven adrenal adenomas with myelolipomatous degeneration: correlation with clinical and pathologic features. Br J Radiol. 2022 Jan 01; 95(1129):20210555.
-
Abnormal body composition in patients with adrenal adenomas. Eur J Endocrinol. 2021 Oct 08; 185(5):653-662.